Sanara MedTech Inc.SMTI
Key ratios
Operating cash flow growth
56.1%TTM
FCF / Sales
4.1%TTM
2025
2.1%2024
-0.3%2023
-5.4%
Net margin
-29.2%TTM
2025
-36.4%2024
-11.2%2023
-6.6%
ROA
7.6%TTM
2025
7.1%2024
1.4%2023
-7.1%
ROE
-1.8%2025
2024
-4.6%2023
-10.3%
Revenue growth
13.0%TTM
2025
19.0%2024
33.4%2023
41.8%
Recent news
Track SMTI in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer